Global Hemoglobin Testing Market Size, Status and Forecast 2019-2025

Hemoglobin is a protein found in the red blood cells (RBCs) that carries out oxygen transportation throughout the body. Hemoglobin tests are carried out to measure the amount of hemoglobin present in the blood. These tests are usually performed during complete blood count as a routine health checkup or to determine the presence of any disease, which could occur due to low count of RBCs. Patients commonly undergo hemoglobin test due to reasons such as fatigue, poor health, or unexplained weight loss. The centralized hemoglobin testing methods are useful for the diagnosis of diabetes and anemia.
A major factor contributing to the growth in this market is growing preference for direct-to-consumer testing. Direct-to-consumer testing is a growing trend in this market as most patients prefer home-care to laboratories. In this mode of testing, the individual does not need to visit laboratories or hospitals for tests as the laboratories send a professional person to the individual's doorstep to collect the blood sample with the help of collection devices. Once, the tests are performed, and results are received, the laboratory sends back the test results electronically to the individual. Advantages like the ease of testing and the availability of quick test results will lead to the high preference for direct-to-consumer testing during the forecast period.
The Americas dominated this market during 2017 and is anticipated to retain its dominating hold over the market until the end of 2023 owing to the high sales of hemoglobin testing products such as analyzers and reagents and consumables. Among all the countries in this region, the market in Brazil and the US will grow rapidly due to the high demand for medical devices. Also, with the increasing preference for point-of-care testing (POCT) among patients, the prospects for growth in this market will have a positive outlook until the end of the forecast period.
In 2018, the global Hemoglobin Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hemoglobin Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemoglobin Testing development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Alere
Danaher
EKF Diagnostics Holdings
F. Hoffmann-La Roche
...

Market segment by Type, the product can be split into
Chromatography
Immunoassay

Market segment by Application, split into
Hospitals
Research Centers
Laboratories

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hemoglobin Testing status, future forecast, growth opportunity, key market and key players.
To present the Hemoglobin Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hemoglobin Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.